Penn State University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Penn State University sits in the top decile of US sponsors by registered trial count (#147 of 15,742 sponsors by registered trial count).
Penn State University: 219 sponsored US clinical trials, 37 recruiting.
Penn State University sponsors 219 registered US clinical trials on ClinicalTrials.gov, 37 of them currently recruiting, and 151 completed. 10 of these trials are in Phase 3-4 (later-stage) and 32 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cardiovascular Disease, with 7 trials.
Top-decile sponsor footprint
Penn State University ranks in the top decile of sponsors by registered trial count (#147 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
151 of 163 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
219 total, page 5 of 5
Increased Calorie Intake to Reverse Energy Deficiency in Exercising Women: Impact on Bone and Menstrual Cyclicity
NCT00392873
Adaptation Processes in School-based Substance Abuse Prevention
NCT02715206
Non-Rhinologic Etiologies of Headaches and Facial Pain in Tertiary Care Setting
NCT00355160
Effectiveness of an Adaptive Treatment Model for At-risk Family Caregivers
NCT00632684
Parent Interventions to Prevent Student Drinking
NCT01126151
Delirium in Persons With Dementia
NCT01394328
The WORLD (Weight Optimization: Revamping Lifestyles Using the Dietary Guidelines) Study - Developing, Implementing, and Testing an Education Program
NCT00847574
Ibuprofen Alone and in Combination With Acetaminophen for Treatment of Fever
NCT00267293
Effect of Honey and Dextromethorphan on Nocturnal Cough and Sleep
NCT00127686
Parent Intervention to Reduce Binge Drinking
NCT01126164
Healthy Sleeping and Feeding During Infancy
NCT00125580
Triple Dye Plus Alcohol Versus Triple Dye Alone for Newborn Umbilical Cord Care
NCT00127699
Enhancing Quality of Life for Nursing Home Residents
NCT00388544
Treatment of Hidradenitis Suppurativa Using Etanercept
NCT00949546
Effect of Valdecoxib Pretreatment on Pain and Secondary Hyperalgesia in Healthy Volunteers
NCT00260325
Family Foundations Coparenting Pilot Trial
NCT01901536
Effect of Acupuncture on Symptoms of Diarrhea and Pain in IBS
NCT00219505
Effect of Menstrual Cycle on Central Nervous System (CNS) Processing of Gut Stimuli in Irritable Bowel Syndrome (IBS) and Control
NCT00219531
Desensitization and Cognitive Therapy in General Anxiety.
NCT00951340
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 21 |
| Phase 2 | 11 |
| Phase 3 | 2 |
| Phase 4 | 8 |
Therapeutic Areas
What is open in the Penn State University pipeline
37 recruiting of 219 indexed (17% open); 151 completed (69%).
Phase mix: 10 late (III/IV) vs 32 early (I/II) (early-phase heavy).
Top condition: Cardiovascular Disease (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Penn State University: open-pipeline peers nationwide
Peers matched on 219 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Penn State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 219 trials (± recruiting share)
- Florida State University · 219 trials · 21% recruiting
- National Eye Institute (NEI) · 221 trials · 8% recruiting
- Otsuka Pharmaceutical Development & Commercialization · 221 trials · 4% recruiting
- University of Louisville · 217 trials · 21% recruiting
Sponsors near 17% open enrollment (± trial volume)
- CSL Behring · 17% recruiting · 71 trials
- University of Hawaii · 17% recruiting · 77 trials
- University of Utah · 17% recruiting · 818 trials
- NYU Langone Health · 17% recruiting · 1,164 trials
Related
What to do with this Penn State University page
219 registered trials is a research-attention snapshot, not an endorsement of Penn State University or any single study.
- 37 of Penn State University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cardiovascular Disease is the condition Penn State University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cardiovascular Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Penn State University pipeline card: 219 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.